Falling AI Token Costs: Why Cheaper AI Could Drive Another Wave of Chip Demand

AI is becoming dramatically cheaper to use. That could create more—not less—demand for chips.

Silicon Data’s benchmark for the cost of one million AI tokens stood at about $0.97 on August 31, down from roughly $2.07 in May.

That is a decline of more than 50% in only a few months.

The important question is:

If AI becomes cheaper, will people simply spend less—or use far more AI?

For semiconductor demand, that distinction matters enormously.

Educational research only. This article is not investment advice.

What Is an AI Token?

AI models process information in tokens.

A token can represent part of:

  • a word;
  • a sentence;
  • computer code;
  • an AI response.

When someone uses an AI chatbot, coding assistant or AI agent, the model consumes tokens.

The cost per token therefore helps measure how expensive AI inference is.

Inference means actually running a trained AI model to answer questions, generate content or perform tasks.

Why AI Is Getting Cheaper

AI costs can fall because of:

  • more efficient models;
  • better chips;
  • improved software;
  • greater server utilization;
  • smaller specialized models;
  • competition between providers.

This improves the economics of deploying AI at scale.

A business that previously found millions of AI interactions too expensive may reconsider once the cost falls dramatically.

Cheaper AI Could Mean Much More AI

This is the most important part.

Suppose the cost of an AI task falls by 50%.

If usage remains unchanged, computing expenditure falls.

But what if cheaper AI causes usage to increase fivefold?

Then total computing demand still rises.

The chain becomes:

Lower token costs → cheaper AI applications → more adoption → more queries and agents → greater compute demand

This is similar to a broader economic idea sometimes called the Jevons effect: making a resource more efficient can sometimes increase total consumption because using it becomes cheaper.

It is not guaranteed.

But it is highly relevant to AI.

AI Agents Could Accelerate Demand

Traditional AI often waits for a person to ask a question.

AI agents can operate much more continuously.

An agent might:

  • research information;
  • write code;
  • analyze files;
  • monitor systems;
  • communicate with other agents;
  • perform repeated business tasks.

That can generate vastly more inference activity than a human occasionally using a chatbot.

DBS analysts have argued that falling token prices could support greater use of applications and agentic AI, creating another wave of computing demand.

This could shift the AI story from:

training bigger models

toward:

running AI everywhere.

Why This Matters for Chip Demand

Training advanced AI models requires powerful accelerators.

Inference also requires chips—especially when millions of users and automated agents operate simultaneously.

The industry is already preparing for that shift.

Chip startup d-Matrix, for example, is developing processors specifically focused on AI inference and is integrating them with Nvidia’s data-center technology.

ASML is also exploring how to increase production of its advanced EUV chipmaking machines beyond 110 units in 2028, with AI demand helping drive customer requirements.

The opportunity therefore extends beyond one chipmaker.

It can reach:

  • foundries;
  • memory suppliers;
  • semiconductor equipment;
  • networking;
  • optical connectivity;
  • power systems;
  • cooling infrastructure.

Singapore Could Benefit Too

This is particularly relevant for Singapore investors.

AEM, UMS Integration and Frencken sit within parts of the semiconductor equipment and manufacturing supply chain.

Their shares have already rallied strongly in 2026 as investors price in AI-driven chip demand.

Analysts cited by The Business Times argue that falling token costs could create another phase of spending if cheaper AI increases overall model usage.

That does not guarantee their rallies continue.

It simply gives the semiconductor cycle another potential demand driver.

What the Macro Model Would Watch

TradingSimuLab’s Macro Model can help place the trend in a broader economic context.

Important questions include:

Is AI investment continuing to accelerate?

Are lower computing costs driving greater adoption?

Is infrastructure spending translating into productivity and revenue?

Are interest rates making large AI projects more expensive to finance?

The macro story is therefore not just about technology.

It is about whether AI adoption grows fast enough to justify enormous infrastructure spending.

What Trend Detector Would Watch

TradingSimuLab’s Trend Detector looks at the quality of the resulting stock-price trend.

Trend Strength

Is the semiconductor stock still moving in an organized direction?

Exhaustion Risk

Has enthusiasm pushed the price too far, too quickly?

EMA Slope

Is the broader trend base still improving?

Distance From Trend

Has price become unusually extended?

This matters because:

strong AI demand does not automatically mean every AI stock has a healthy entry point.

What Could Break the Thesis?

Cheaper AI will not automatically create unlimited chip demand.

Risks include:

  • model efficiency improving faster than usage;
  • companies reducing AI spending;
  • weaker AI monetization;
  • regulatory restrictions;
  • excessive data-center capacity;
  • already-stretched semiconductor valuations.

AI safety concerns also triggered a sharp global chip-stock selloff on September 14, showing how quickly market expectations can change.

Final Takeaway

Falling AI token costs could become one of the next major drivers of the semiconductor cycle.

The key relationship is:

Cheaper AI → More Usage → More Inference → More Compute → More Chip Demand

But only if usage grows faster than efficiency improves.

That is why the better question is not:

“Is AI getting cheaper?”

It clearly is.

The real question is:

“How much additional AI usage will cheaper computing unlock?”

That could determine whether the next phase of the AI boom is driven less by training enormous models—and more by running AI everywhere.

For more market research tools, macro analysis and trend insights, sign up to TradingSimuLab and explore the platform.

Continue exploring TradingSimuLab.

  • Software Stocks: Can AI Turn From a Threat Into a Revenue Opportunity?

    If artificial intelligence could build applications, automate workflows and let companies create their own tools, why keep paying large subscription fees to traditional software providers? That fear hit companies such as Salesforce and ServiceNow hard. Now the story may be changing. Salesforce recently reported its strongest growth in net new annual order value in four…

  • AI Training Data: Is Data Becoming More Valuable Than the Model?

    The AI race is no longer only about building bigger models. Increasingly, it is also about building better data. That shift is visible in the rise of Snorkel AI, which recently raised $350 million at a $3.5 billion valuation as demand grows for specialized datasets, reinforcement-learning environments and expert-generated training material. Its annualized revenue has…

  • Why Shipping Costs Can Move Oil Prices Even When Supply Is Available

    Oil prices can rise even when plenty of crude exists. One reason is often overlooked: shipping costs. Recent Venezuelan crude trades show the problem clearly. Reuters reported that tanker costs from Venezuela’s Jose port to the U.S. Gulf had risen to roughly $3.5 million per Aframax voyage, forcing traders to demand deeper discounts on the…

  • Currency Intervention Explained: Can Governments Stop a Falling Currency?

    A currency can keep falling even after interest rates rise. That is exactly why currency intervention periodically returns to the spotlight. The Japanese yen recently traded around 157.5 per U.S. dollar despite the Bank of Japan raising its policy rate to 1.25%. Markets remain alert to another possible intervention after reports of Japanese authorities checking…

  • India Stock Market: Why Global Banks Are Rushing Back In

    Global banks are paying closer attention to India’s capital markets. HSBC is preparing to re-enter India’s equity-broking business after more than a decade away, rebuilding its equities platform as IPO activity and demand from wealthy investors expand. Reuters reports that the bank is hiring for cash-equities and institutional-broking roles and may also relaunch retail broking…

  • Solar Stocks India: Can Domestic Panel Makers Compete With China?

    India is building a much larger domestic solar manufacturing industry. One of the clearest signs is Avaada Electro, which is preparing a major IPO as it expands solar-cell and module production. The company currently has about 8.5 GW of module capacity and is targeting 13.6 GW, alongside major expansion in solar-cell manufacturing. For investors watching…

  • Japan Bond Yields: Why Higher Rates Can Move Global Markets

    For decades, Japanese investors sent enormous amounts of money overseas in search of higher returns. That may be starting to change. Japan bond yields recently pushed above 3% on the 10-year government bond, the highest level since 1996. At the same time, Japanese investors have begun reducing some overseas bond exposure as domestic bonds become…

  • Corporate Governance Explained: Why Shareholder Rights Matter as Much as Earnings

    Investors spend enormous amounts of time studying revenue, margins and earnings. But sometimes the biggest risk sits somewhere else: Who actually controls the company? A recent dispute inside India’s Tata Group has brought corporate governance back into focus. Tata Sons and its controlling shareholder, Tata Trusts, have clashed over board authority, the reappointment of chairman…

  • Pharmaceutical Stocks: Why Europe Is Losing Ground in Drug Research

    Europe has some of the world’s largest pharmaceutical companies. But an increasing share of global drug research is happening elsewhere. European drugmakers say the region’s share of global pharmaceutical R&D has fallen from about 43% to 31%, while its share of commercial clinical trials has dropped to roughly 9% over the past decade. Industry leaders…